Controversies in the Spleen: Histiocytic, Dendritic, and Stromal Cell Lesions

Surg Pathol Clin. 2023 Jun;16(2):385-400. doi: 10.1016/j.path.2023.01.004. Epub 2023 Mar 8.

Abstract

Histiocytic, dendritic, and stromal cell lesions that occur in the spleen are challenging diagnostically, not well studied due to their rarity, and therefore somewhat controversial. New techniques for obtaining tissue samples also create challenges as splenectomy is no longer common and needle biopsy does not afford the same opportunity for examination of tissue. Characteristic primary splenic histiocytic, dendritic, and stromal cell lesions are presented in this paper with new molecular genetic findings in some entities that help differentiate these lesions from those occurring in non-splenic sites, such as soft tissue, and identify possible molecular markers for diagnosis.

Keywords: EBV-positive inflammatory follicular dendritic cell sarcoma; Histiocytic sarcoma; Inflammatory pseudotumor; Mesothelial cyst; Sclerosing angiomatoid nodular transformation; Spleen.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Splenectomy / methods
  • Splenic Neoplasms* / diagnosis
  • Splenic Neoplasms* / genetics
  • Splenic Neoplasms* / pathology

Substances

  • Biomarkers